Immunization against Leishmania major infection in BALB/c mice using a subunit-based DNA vaccine derived from TSA, LmSTI1, KMP11, and LACK predominant antigens

OBJECTIVE(S): To design a multivalent DNA vaccine encoding the most immunogenic regions of the Leishmania major antigens including TSA (Thiol-specific antioxidant protein), LmSTI1 (Leishmania major stress-inducible protein1), LACK (Leishmania homologue of receptors for activated C Kinase), and KMP11...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Iran J Basic Med Sci
Main Authors: Salehi-Sangani, Ghodratollah, Mohebali, Mehdi, Jajarmi, Vahid, Khamesipour, Ali, Bandehpour, Mojgan, Mahmoudi, Mahmoud, Zahedi-Zavaram, Hadi
Formato: Artigo
Idioma:Inglês
Publicado: Mashhad University of Medical Sciences 2019
Assuntos:
Original Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7043880/
https://ncbi.nlm.nih.gov/pubmed/32133069
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.22038/IJBMS.2019.14051
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares